Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Research Report 2025
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Report 2025" has been added to ResearchAndMarkets.com's offering.
The artificial intelligence (AI) in in vitro diagnostics (IVD) market is experiencing robust growth, projected to expand from $2.57 billion in 2024 to $3.04 billion in 2025, marking a compound annual growth rate (CAGR) of 18.5%. This upward trend continues, with market size anticipated to reach $5.94 billion by 2029 at a CAGR of 18.2%. Key drivers include the need for rapid diagnostic results, prevalence of chronic diseases, and the demand for personalized medicine.
Advancements in AI-driven diagnostics are transforming healthcare, particularly in the realm of personalized medicine. By evaluating complex patient data, AI supports tailored treatment plans, enhancing diagnostic accuracy. The FDA's 2024 approval of 16 personalized treatments highlights this trend, notably in rare diseases and cancer, reflecting the growing reliance on personalized medicine in the medical field.
Companies like Diagnostics.ai are pushing the envelope with innovations like PCR.AI, a cutting-edge solution launched in May 2025. This platform automates PCR result interpretation with over 99.9% accuracy, streamlining workflows and ensuring high diagnostic precision. PCR.AI sets a benchmark in regulatory compliance and clinical trust, significantly improving laboratory efficiency and reducing error margins.
Strategic collaborations are also advancing the sector. In April 2025, bioMerieux SA partnered with Mila, a leading AI research institute, to enhance diagnostic tools, with a focus on antibiotic resistance detection. Such partnerships underscore the importance of integrating AI with diagnostic technology to tackle critical medical challenges.
Market leaders include Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., and Abbott Laboratories, among others. These key players are strengthening their positions with AI-enabled technologies that refine diagnostic processes. Regional market dynamics reveal North America as the largest and Asia-Pacific as the fastest-growing market, reflecting diverse consumer demands and technological adoption rates.
The market's evolution is not without challenges. Trade tensions and tariffs, particularly those arising in 2025, pose risks to supply chains and cost structures. Companies are adopting strategies like dual-sourcing and increased domestic production to mitigate these issues, highlighting the sector's resilience and adaptability in a shifting global landscape.
AI in IVD encompasses software, hardware, and service components leveraging cutting-edge technologies like machine learning and natural language processing. Applications range from diagnostic imaging to genomics, serving end users across hospitals, clinics, and pharmaceutical firms.
Delivering comprehensive insights, the AI in IVD market report provides critical statistics, competitor analysis, and strategic guidance, invaluable for stakeholders navigating the complex healthcare ecosystem. With an emphasis on real-time data and future trends, the report is an essential tool for understanding market dynamics and capitalizing on emerging opportunities.
Key Benefits of the Report:
Key Attributes:
Table of Contents
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/4otnuc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment